Céline Prunier

2.0k total citations
40 papers, 1.6k citations indexed

About

Céline Prunier is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Céline Prunier has authored 40 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 15 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Céline Prunier's work include TGF-β signaling in diseases (21 papers), Cancer-related gene regulation (11 papers) and Pancreatic and Hepatic Oncology Research (10 papers). Céline Prunier is often cited by papers focused on TGF-β signaling in diseases (21 papers), Cancer-related gene regulation (11 papers) and Pancreatic and Hepatic Oncology Research (10 papers). Céline Prunier collaborates with scholars based in France, United States and Belgium. Céline Prunier's co-authors include Azeddine Atfi, Philip H. Howe, Nathalie Ferrand, Barbara A. Hocevar, Anne Mazars, Marcia Pessah, François Lallemand, Gisèle Cherqui, Marie‐Françoise Bourgeade and Jean‐Michel Gauthier and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Céline Prunier

40 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Céline Prunier France 24 1.3k 397 201 150 142 40 1.6k
Nathalie Ferrand France 22 1.0k 0.8× 353 0.9× 180 0.9× 82 0.5× 142 1.0× 51 1.3k
Tam How United States 19 1.2k 1.0× 439 1.1× 235 1.2× 245 1.6× 77 0.5× 24 1.6k
Petra Vermassen Belgium 8 1.0k 0.8× 551 1.4× 300 1.5× 149 1.0× 152 1.1× 11 1.3k
Mayshan Ghiassi United States 11 1.2k 0.9× 566 1.4× 216 1.1× 203 1.4× 75 0.5× 13 1.7k
Sina Koch Germany 15 1.3k 1.0× 417 1.1× 288 1.4× 161 1.1× 53 0.4× 22 2.0k
Célio Pouponnot France 22 1.9k 1.5× 522 1.3× 233 1.2× 183 1.2× 224 1.6× 41 2.3k
Ayako Nishihara Japan 11 1.5k 1.1× 318 0.8× 142 0.7× 125 0.8× 107 0.8× 14 1.8k
Jesús V. Soriano Switzerland 19 886 0.7× 494 1.2× 154 0.8× 136 0.9× 194 1.4× 25 1.3k
Jennifer A. Doll United States 21 921 0.7× 363 0.9× 371 1.8× 169 1.1× 192 1.4× 29 1.6k
Anil K. Kamaraju United States 9 750 0.6× 318 0.8× 196 1.0× 199 1.3× 107 0.8× 10 1.4k

Countries citing papers authored by Céline Prunier

Since Specialization
Citations

This map shows the geographic impact of Céline Prunier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Prunier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Prunier more than expected).

Fields of papers citing papers by Céline Prunier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Céline Prunier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Prunier. The network helps show where Céline Prunier may publish in the future.

Co-authorship network of co-authors of Céline Prunier

This figure shows the co-authorship network connecting the top 25 collaborators of Céline Prunier. A scholar is included among the top collaborators of Céline Prunier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Céline Prunier. Céline Prunier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boissan, Mathieu, Ivan Bièche, Florent Dingli, et al.. (2024). CYYR1 promotes the degradation of the E3 ubiquitin ligase WWP1 and is associated with favorable prognosis in breast cancer. Journal of Biological Chemistry. 300(9). 107601–107601. 3 indexed citations
2.
Hurwitz, Eric, Parash Parajuli, Céline Prunier, et al.. (2023). Antagonism between Prdm16 and Smad4 specifies the trajectory and progression of pancreatic cancer. The Journal of Cell Biology. 222(4). 10 indexed citations
3.
Boëda, Batiste, Sabrina Colasse, Florent Dingli, et al.. (2023). The UAS thioredoxin-like domain of UBXN7 regulates E3 ubiquitin ligase activity of RNF111/Arkadia. BMC Biology. 21(1). 73–73. 1 indexed citations
4.
Dingli, Florent, Sabrina Colasse, Isabelle Petit, et al.. (2021). Quantitative Ubiquitylome Analysis Reveals the Specificity of RNF111/Arkadia E3 Ubiquitin Ligase for its Degradative Substrates SKI and SKIL/SnoN in TGF-β Signaling Pathway. Molecular & Cellular Proteomics. 20. 100173–100173. 8 indexed citations
5.
Parajuli, Parash, et al.. (2020). Pancreatic cancer triggers diabetes through TGF-β–mediated selective depletion of islet β-cells. Life Science Alliance. 3(6). e201900573–e201900573. 20 indexed citations
6.
Parajuli, Parash, Audrey Loumaye, Purba Singh, et al.. (2018). Twist1 Activation in Muscle Progenitor Cells Causes Muscle Loss Akin to Cancer Cachexia. Developmental Cell. 45(6). 712–725.e6. 46 indexed citations
7.
Zhang, Mingzhu, Olivier Ferrigno, Zhe Wang, et al.. (2015). TGIF Governs a Feed-Forward Network that Empowers Wnt Signaling to Drive Mammary Tumorigenesis. Cancer Cell. 27(4). 547–560. 52 indexed citations
8.
Ferrand, Nathalie, Azeddine Atfi, & Céline Prunier. (2010). The Oncoprotein c-Ski Functions as a Direct Antagonist of the Transforming Growth Factor-β Type I Receptor. Cancer Research. 70(21). 8457–8466. 23 indexed citations
9.
10.
Faresse, Nourdine, Frédéric Colland, Nathalie Ferrand, et al.. (2008). Identification of PCTA, a TGIF antagonist that promotes PML function in TGF‐β signalling. The EMBO Journal. 27(13). 1804–1815. 31 indexed citations
11.
Atfi, Azeddine, Frédéric Colland, Dominique Bonnier, et al.. (2007). The disintegrin and metalloproteinase ADAM12 contributes to TGF-β signaling through interaction with the type II receptor. The Journal of Cell Biology. 178(2). 201–208. 97 indexed citations
12.
Jiang, Yong, Céline Prunier, & Philip H. Howe. (2007). The inhibitory effects of Disabled-2 (Dab2) on Wnt signaling are mediated through Axin. Oncogene. 27(13). 1865–1875. 45 indexed citations
13.
Seo, Su Ryeon, Nathalie Ferrand, Nourdine Faresse, et al.. (2006). Nuclear Retention of the Tumor Suppressor cPML by the Homeodomain Protein TGIF Restricts TGF-β Signaling. Molecular Cell. 23(4). 547–559. 63 indexed citations
14.
Prunier, Céline & Philip H. Howe. (2005). Disabled-2 (Dab2) Is Required for Transforming Growth Factor β-induced Epithelial to Mesenchymal Transition (EMT). Journal of Biological Chemistry. 280(17). 17540–17548. 109 indexed citations
15.
Hocevar, Barbara A., Céline Prunier, & Philip H. Howe. (2005). Disabled-2 (Dab2) Mediates Transforming Growth Factor β(TGFβ)-stimulated Fibronectin Synthesis through TGFβ-activatedKinase 1 and Activation of the JNKPathway. Journal of Biological Chemistry. 280(27). 25920–25927. 98 indexed citations
16.
Prunier, Céline, Marcia Pessah, Nathalie Ferrand, et al.. (2003). The Oncoprotein Ski Acts as an Antagonist of Transforming Growth Factor-β Signaling by Suppressing Smad2 Phosphorylation. Journal of Biological Chemistry. 278(28). 26249–26257. 48 indexed citations
17.
Lallemand, François, Céline Prunier, Nathalie Ferrand, et al.. (2003). Evidence for a Role of Smad3 and Smad2 in Stabilization of the Tumor-derived Mutant Smad2.Q407R. Journal of Biological Chemistry. 278(27). 24881–24887. 12 indexed citations
18.
Dennler, Sylviane, Céline Prunier, Nathalie Ferrand, Jean‐Michel Gauthier, & Azeddine Atfi. (2000). c-Jun Inhibits Transforming Growth Factor β-mediated Transcription by Repressing Smad3 Transcriptional Activity. Journal of Biological Chemistry. 275(37). 28858–28865. 77 indexed citations
19.
Prunier, Céline, Anne Mazars, Veerle Noë, et al.. (1999). Evidence That Smad2 Is a Tumor Suppressor Implicated in the Control of Cellular Invasion. Journal of Biological Chemistry. 274(33). 22919–22922. 45 indexed citations
20.
Atfi, Azeddine, Céline Prunier, Anne Mazars, et al.. (1999). The oncogenic TEL/PDGFRβ fusion protein induces cell death through JNK/SAPK pathway. Oncogene. 18(26). 3878–3885. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026